Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $3.14 billion. The enterprise value is $2.79 billion.
| Market Cap | 3.14B |
| Enterprise Value | 2.79B |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 96.50 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Shares Outstanding | 96.50M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 101.56% |
| Float | 83.93M |
Valuation Ratios
The trailing PE ratio is 52.58 and the forward PE ratio is 46.04.
| PE Ratio | 52.58 |
| Forward PE | 46.04 |
| PS Ratio | 2.89 |
| Forward PS | 2.38 |
| PB Ratio | 5.68 |
| P/FCF Ratio | 16.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.08, with an EV/FCF ratio of 15.08.
| EV / Earnings | 45.01 |
| EV / Sales | 2.56 |
| EV / EBITDA | 40.08 |
| EV / EBIT | 41.43 |
| EV / FCF | 15.08 |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.44 |
| Quick Ratio | 3.30 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.09 |
| Interest Coverage | -20.40 |
Financial Efficiency
Return on equity (ROE) is 12.60% and return on invested capital (ROIC) is 9.56%.
| Return on Equity (ROE) | 12.60% |
| Return on Assets (ROA) | 8.80% |
| Return on Capital (ROIC) | 9.56% |
| Revenue Per Employee | $1.92M |
| Profits Per Employee | $109,606 |
| Employee Count | 566 |
| Asset Turnover | 1.55 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $8.65 million in taxes.
| Income Tax | 8.65M |
| Effective Tax Rate | 12.24% |
Stock Price Statistics
The stock price has decreased by -5.56% in the last 52 weeks. The beta is 1.48, so Progyny's price volatility has been higher than the market average.
| Beta (1Y) | 1.48 |
| 52-Week Price Change | -5.56% |
| 50-Day Moving Average | 36.23 |
| 200-Day Moving Average | 36.14 |
| Relative Strength Index (RSI) | 36.03 |
| Average Volume (30 Days) | 845,962 |
Short Selling Information
The latest short interest is 6.53 million, so 6.77% of the outstanding shares have been sold short.
| Short Interest | 6.53M |
| Short Previous Month | 6.20M |
| Short % of Shares Out | 6.77% |
| Short % of Float | 7.78% |
| Short Ratio (days to cover) | 6.09 |
Income Statement
In the last 12 months, Progyny had revenue of $1.09 billion and earned $62.04 million in profits. Earnings per share was $0.62.
| Revenue | 1.09B |
| Gross Profit | 238.80M |
| Operating Income | 62.18M |
| Pretax Income | 70.69M |
| Net Income | 62.04M |
| EBITDA | 69.67M |
| EBIT | 67.39M |
| Earnings Per Share (EPS) | $0.62 |
Balance Sheet
The company has $371.09 million in cash and $17.24 million in debt, giving a net cash position of $353.85 million or $3.67 per share.
| Cash & Cash Equivalents | 371.09M |
| Total Debt | 17.24M |
| Net Cash | 353.85M |
| Net Cash Per Share | $3.67 |
| Equity / Book Value | 553.43M |
| Book Value Per Share | 5.74 |
| Working Capital | 454.46M |
Cash Flow
In the last 12 months, operating cash flow was $188.81 million and capital expenditures -$3.64 million, giving a free cash flow of $185.17 million.
| Operating Cash Flow | 188.81M |
| Capital Expenditures | -3.64M |
| Free Cash Flow | 185.17M |
| FCF Per Share | $1.95 |
Margins
Gross margin is 21.94%, with operating and profit margins of 5.71% and 5.70%.
| Gross Margin | 21.94% |
| Operating Margin | 5.71% |
| Pretax Margin | 6.49% |
| Profit Margin | 5.70% |
| EBITDA Margin | 6.40% |
| EBIT Margin | 6.19% |
| FCF Margin | 17.01% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.72% |
| Earnings Yield | 1.97% |
| FCF Yield | 5.89% |
Analyst Forecast
The average price target for Progyny is $48.71, which is 49.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $48.71 |
| Price Target Difference | 49.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 18.74% |
| EPS Growth Forecast (5Y) | 31.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 11.91 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.91 |
| Piotroski F-Score | 6 |